India faces rising diabetes and obesity rates. With new generic semaglutide versions emerging, experts warn about potential misuse and the importance of medical supervision. Safety, consistent quality, and informed use are crucial for effective diabetes and obesity management.
​India faces rising diabetes and obesity rates. With new generic semaglutide versions emerging, experts warn about potential misuse and the importance of medical supervision. Safety, consistent quality, and informed use are crucial for effective diabetes and obesity management. by Soban News (international And National News)
